English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

1 Junior Resident, Department of Medicine, Patna Medical College & Hospital 2 Professor, Department of Medicine, Patna Medical College & Hospital *Corresponding Author Dr Kaushal Kishore Abstract Dyslipidemia, is considered as an important risk factor for cardiovascular disease which is frequently complicated with diabetic nephropathy. Management of dyslipidemia in diabetic nephropathy is an extremely important factor because patients with diabetic nephropathy are at a high risk for cardiovascular disease-associated death. Methods: The present study was conducted to explore the lipid abnormalities in diabetic patients with nephropathy in comparison with diabetic patients without nephropathy. This cross sectional study was conducted in the Department of General Medicine, OPD, & IPD of Patna Medical College & Hospital. This study included total 60 patients divided in two groups: diabetic patients with nephropathy group and diabetic patients without nephropathy group. Available data between two groups were analysed. Results: In our study the commonest age group was 51-60 years in both groups. The mean age of patients in nephropathy and without nephropathy group was 51.96±8.81 and 51.466±7.62 years respectively. We observed no significant difference for age group between two groups. While comparing the mean fasting and postprandial blood glucose level and HbA1c level between two group nephropathy groups showed significantly higher level compared to without nephropathy group. The percentage of subjects with dyslipidemia was significantly higher in nephropathy group in this study. Conclusion: Dyslipidemia is an important therapeutic target in the management of diabetes. Furthermore, diabetic nephropathy accelerates abnormal lipoprotein metabolism, which causes the progression of DN as well as cardiovascular disease.

Comparative study of Dyslipidemia in Diabetic patients with Diabetic Nephropathy and Diabetic patients without Nephropathy